Claritev Stock Performance
| CTEV Stock | 42.71 1.87 4.19% |
Claritev holds a performance score of 18 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.25, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Claritev will likely underperform. Use Claritev coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to analyze future returns on Claritev.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Claritev are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak technical and fundamental indicators, Claritev showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (4.19) | Five Day Return (9.32) | Year To Date Return 46.27 | Ten Year Return 46.27 | All Time Return 46.27 |
1 | Acquisition by Clarke Richard A of 7356 shares of Claritev subject to Rule 16b-3 | 04/30/2025 |
2 | Claritev reports Q1 results | 05/08/2025 |
3 | Acquisition by Douglas Garis of 11689 shares of Claritev at 21.95 subject to Rule 16b-3 | 05/12/2025 |
4 | Acquisition by Douglas Garis of 3600 shares of Claritev at 27.73 subject to Rule 16b-3 | 05/19/2025 |
5 | Claritev and Burjeel Holdings Finalize Strategic Collaboration, Marks Claritevs Expansion into ... | 05/22/2025 |
6 | Claritev Upgraded to Overweight at Piper Sandler with a 44 Price Target | 05/29/2025 |
7 | Acquisition by Tiffani Misencik of 20247 shares of Claritev subject to Rule 16b-3 | 06/02/2025 |
8 | Claritev Corp Shares Up 3.1 percent on Jun 5 | 06/05/2025 |
9 | Claritev Joins Coalition for Health AI to Advance Responsible Innovation in Healthcare ... | 06/17/2025 |
10 | Claritev Corporation Joins Coalition for Health AI to Advance Responsible AI in Healthcare | 06/25/2025 |
11 | Claritev Corp Stock Price Up 8.03 percent on Jun 30 | 06/30/2025 |
12 | Claritevs PHCS Network Receives Twelfth Consecutive NCQA Accreditation in Credentialing | 07/08/2025 |
13 | Claritev Corporations Price Is Right But Growth Is Lacking After Shares Rocket 25 | 07/09/2025 |
14 | Claritev Corp Stock Price Down 3.61 percent on Jul 11 | 07/11/2025 |
15 | Claritev Releases 2024 Corporate Responsibility Report | 07/16/2025 |
16 | Claritev Joins athenahealths Marketplace Program to Empower Providers with Price Intelligence ... | 07/17/2025 |
| Begin Period Cash Flow | 81.5 M | |
| Total Cashflows From Investing Activities | -118.1 M |
Claritev Relative Risk vs. Return Landscape
If you would invest 1,957 in Claritev on April 21, 2025 and sell it today you would earn a total of 2,314 from holding Claritev or generate 118.24% return on investment over 90 days. Claritev is currently generating 1.3948% in daily expected returns and assumes 5.8126% risk (volatility on return distribution) over the 90 days horizon. In different words, 52% of stocks are less volatile than Claritev, and 72% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Claritev Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Claritev's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Claritev, and traders can use it to determine the average amount a Claritev's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.24
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | CTEV | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.81 actual daily | 52 52% of assets are less volatile |
Expected Return
| 1.39 actual daily | 28 72% of assets have higher returns |
Risk-Adjusted Return
| 0.24 actual daily | 18 82% of assets perform better |
Based on monthly moving average Claritev is performing at about 18% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Claritev by adding it to a well-diversified portfolio.
Claritev Fundamentals Growth
Claritev Stock prices reflect investors' perceptions of the future prospects and financial health of Claritev, and Claritev fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Claritev Stock performance.
| Shares Outstanding | 16 M | ||||
| Revenue | 930.62 M | ||||
| EBITDA | (1.01 B) | ||||
| Net Income | (1.65 B) | ||||
| Total Debt | 4.54 B | ||||
| Cash Flow From Operations | 107.62 M | ||||
| Total Asset | 5.15 B | ||||
| Retained Earnings | (2.15 B) | ||||
| Working Capital | (38.27 M) | ||||
About Claritev Performance
Evaluating Claritev's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Claritev has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Claritev has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (3.16) | (3.00) | |
| Return On Capital Employed | (0.28) | (0.27) | |
| Return On Assets | (0.32) | (0.30) | |
| Return On Equity | (19.59) | (18.61) |
Things to note about Claritev performance evaluation
Checking the ongoing alerts about Claritev for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Claritev help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Claritev is way too risky over 90 days horizon | |
| Claritev appears to be risky and price may revert if volatility continues | |
| Claritev has high likelihood to experience some financial distress in the next 2 years | |
| Claritev was previously known as MPLN Old and was traded on NASDAQ Exchange under the symbol MPLN. | |
| The company reported the previous year's revenue of 930.62 M. Net Loss for the year was (1.65 B) with profit before overhead, payroll, taxes, and interest of 0. | |
| Latest headline from gurufocus.com: Claritev Joins athenahealths Marketplace Program to Empower Providers with Price Intelligence ... |
- Analyzing Claritev's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Claritev's stock is overvalued or undervalued compared to its peers.
- Examining Claritev's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Claritev's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Claritev's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Claritev's stock. These opinions can provide insight into Claritev's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Claritev Stock Analysis
When running Claritev's price analysis, check to measure Claritev's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Claritev is operating at the current time. Most of Claritev's value examination focuses on studying past and present price action to predict the probability of Claritev's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Claritev's price. Additionally, you may evaluate how the addition of Claritev to your portfolios can decrease your overall portfolio volatility.